Axsome Therapeutics (AXSM) Total Debt Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -5.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.66% |
| Dec 31, 2025 | 8.45% |
| Sep 30, 2025 | 8.06% |
| Jun 30, 2025 | 23.56% |
| Mar 31, 2025 | 56.76% |
| Dec 31, 2024 | 54.41% |
| Sep 30, 2024 | 56.40% |
| Jun 30, 2024 | 56.22% |
| Mar 31, 2024 | 56.16% |
| Dec 31, 2023 | 56.29% |
| Sep 30, 2023 | 56.51% |
| Jun 30, 2023 | 108.21% |
| Mar 31, 2023 | 96.93% |
| Dec 31, 2022 | 71.27% |
| Sep 30, 2022 | 72.22% |
| Jun 30, 2022 | 71.87% |
| Mar 31, 2022 | 36.58% |
| Dec 31, 2021 | 92.23% |
| Sep 30, 2021 | 85.32% |
| Jun 30, 2021 | 79.37% |
| Mar 31, 2021 | 74.11% |
| Dec 31, 2020 | 69.45% |
| Sep 30, 2020 | 68.20% |
| Jun 30, 2020 | 26.72% |
| Mar 31, 2020 | 26.84% |
| Dec 31, 2019 | 26.97% |